Home › Amyotrophic Lateral Sclerosis › Ohio › Columbus
Amyotrophic Lateral Sclerosis clinical trials in Columbus, OH
4 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
RecruitingPhase 1
- USA007, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- The Ohio State University, Department of Psychiatry, Columbus
PREVENT ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- Ohio State University, Columbus
A Study of Ranolazine in ALS
RecruitingPhase 2
- The Ohio State University, Columbus
About Amyotrophic Lateral Sclerosis
ALS stands for Amyotrophic Lateral Sclerosis, also called Lou Gehrig's disease. ALS affects the nervous system, causing muscle problems. Find out how.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Philadelphia, PA14 studies
- Baltimore, MD13 studies
- Jacksonville, FL13 studies
- New York City, NY11 studies
- San Francisco, CA10 studies
- San Diego, CA10 studies
- Chicago, IL10 studies
- St. Louis, MO9 studies
- Phoenix, AZ8 studies
- Dallas, TX8 studies
- Atlanta, GA8 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.